Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Experimental Neoplasms

zidovudine has been researched along with Experimental Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Alexandrova, SS; Angeli, A; Berrino, E; Carta, F; Ferraroni, M; Gladilina, YA; Hilal, A; Khan, II; Plyasova, AA; Pokrovskaya, MV; Pokrovsky, VS; Sokolov, NN; Supuran, CT; Veselovsky, AV; Zhdanov, DD1
Aschacher, T; Bergmann, M; Bernhard, D; Holzmann, K; Käser, L; Sampl, S; Spittler, A1
Rowe, PM1
Nersesyan, AK1
Anderson, LM; Diwan, BA; Haines, DC; Logsdon, D; Olivero, OA; Poirier, MC; Rice, JM; Riggs, CW; Yuspa, SH1
Blackstock, W; Feng, W; Israel, B; Kenney, SC; Westphal, EM1

Other Studies

6 other study(ies) available for zidovudine and Experimental Neoplasms

ArticleYear
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors.
    Journal of medicinal chemistry, 2021, 08-12, Volume: 64, Issue:15

    Topics: Animals; Antineoplastic Agents; Carbonic Anhydrases; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Sulfonamides; Telomerase; Tumor Cells, Cultured; Zidovudine

2021
The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.
    Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Cell Line, Tumor; Didanosine; Fluorescent Antibody Technique; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Mice; Mice, Nude; Neoplasms, Experimental; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Telomere; Telomere Shortening; Xenograft Model Antitumor Assays; Zidovudine

2012
US expert panel reaffirms benefit of perinatal zidovudine.
    Lancet (London, England), 1997, Jan-25, Volume: 349, Issue:9047

    Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Female; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mice; Neoplasms, Experimental; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

1997
Re: Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.
    Journal of the National Cancer Institute, 1998, Aug-05, Volume: 90, Issue:15

    Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Female; Male; Maternal-Fetal Exchange; Mice; Neoplasms, Experimental; Pregnancy; Prenatal Exposure Delayed Effects; Zidovudine

1998
Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
    Toxicology and applied pharmacology, 1999, Nov-15, Volume: 161, Issue:1

    Topics: Animals; Animals, Newborn; Anti-HIV Agents; Barbital; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Maternal-Fetal Exchange; Mice; Neoplasms, Experimental; Pregnancy; Survival Rate; Time Factors; Urogenital Neoplasms; Zidovudine

1999
Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Cancer research, 2000, Oct-15, Volume: 60, Issue:20

    Topics: Animals; Antiviral Agents; B-Lymphocytes; Biotransformation; Burkitt Lymphoma; Butyrates; Cell Death; Cell Line, Transformed; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Lymphocytes; Mice; Mice, SCID; Neoplasms, Experimental; Stomach Neoplasms; Tumor Virus Infections; Virus Activation; Xenograft Model Antitumor Assays; Zidovudine

2000